Blizzard Entertainment, the American video game developer and publisher behind the StarCraft series, announced that AlphaStar will join the competitive ladder in Europe on the online gaming platform Battle.net, where it will play a limited number of games against human players.
DeepMind is a trailblazer in the trending computer vs humans gaming research space. Following milestone victories against human pros on the board game Go and video game StarCraft II, the Google-owned research company has now pitted their new AI system against humans in the first-person shooter multiplayer video game Quake III Arena.
DeepMind trained and tested its neural model by first collecting a dataset consisting of different types of mathematics problems. Rather than crowd-sourcing, they synthesized the dataset to generate a larger number of training examples, control the difficulty level and reduce training time.
Facing the incomplete information environment, the asynchronous neural virtual self-play (ANFSP) method allows AI to learn to generate optimal decisions in multiple virtual environments. The approach has performed well in Texas Hold’em and multiplayer FPS video games.
DeepMind’s Research Platform Team has open-sourced TF-Replicator, a framework that enables researchers without previous experience with the distributed system to deploy their TensorFlow models on GPUs and Cloud TPUs. The move aims to strengthen AI research and development.
Having notched impressive victories over human professionals in Go, Atari Games, and most recently StarCraft 2 — Google’s DeepMind team has now turned its formidable research efforts to soccer. In a paper released last week, the UK AI company demonstrates a novel machine learning method that trains a team of AI agents to play a simulated version of “the beautiful game.”
DeepMind bot AlphaStar has scored a convincing 10/10 victory against pro human players in a special series of StarCraft II matches. Plucky 26 year-old Polish gamer Grzegorz “MaNa” Komincz however salvaged a bit of human pride, snatching a surprise win yesterday in a live rematch at the DeepMind and Blizzard Entertainment Starcraft II Demonstration live stream event hosted in London.
In 2016 Google’s DeepMind stunned the world when their Go computer AlphaGo secured a historic victory over Korean grandmaster Lee Sedol. Yesterday the UK’s top AI team delivered their latest “wow moment” as their AI system AlphaFold topped the Critical Assessment of Structure Prediction (CASP) competition.
DeepMind announced today that it has opened its Graph Nets (GN) library to the public, enabling the use of graph networks in TensorFlow and Sonnet. Graph Nets is a machine learning framework that was published by DeepMind, Google Brain, MIT and University of Edinburgh on Jun 15.
Last month’s ReWork Deep Learning Summit in London provided a peek at current recent research progress and future trends in artificial intelligence technologies. The two-day event featured top scientists and engineers from Facebook, MIT Media lab, DeepMind and other leading institutes.
“Best GAN samples ever yet? Very impressive ICLR submission! BigGAN improves Inception Scores by >100.” The above Tweet is from renowned Google DeepMind research scientist Oriol Vinyals. It was retweeted last week by Google Brain researcher and “Father of Generative Adversarial Networks” Ian Goodfellow, and picked up momentum and praise from AI researchers on social media.
Blockchain hardware, software, and services company Bitmain confirms it will build a data center in Rockdale, Texas and invest US$500 million in the United States over the next seven years. Bitmain will launch a local training program and hire more than 400 employees.
Artificial intelligence can now match or outperform human experts in diagnosis and referral on eye diseases, suggests a new paper from DeepMind. The UK-based, Google-owned research institute today released joint research results with the UK’s Moorfields Eye Hospital and UCL Institute of Ophthalmology, which present a new AI technique in the context of OCT imaging. The paper was published on Nature Medicine’s website.